- Mercia Technologies said it had made a new direct investment of £0.5m in specialist regenerative medicine company Locate Bio.

Based in Nottingham, Locate had been working for over a decade on developing a novel drug delivery system and associated gene editing technologies, with an initial focus on orthopaedic applications.

Its lead product was a treatment for osteomyelitis, for which Locate had partnered with a major European medical device developer.

In addition, it was developing a product to precisely control bone growth. Following the initial investment, Mercia said it would hold a 6.0% equity stake in Locate.

At 9:54am: [LON:MERC] Mercia Technologies Plc share price was 0p at 30p

Story provided by